The DOI matches its Crossref record; 193 of the 193 references it cites were found in a registry or an index.
The Membrane-Proximal External Region of the Human Immunodeficiency Virus Type 1 Envelope: Dominant Site of Antibody Neutralization and Target for Vaccine Design
Open accessAbstract
SUMMARY: Enormous efforts have been made to produce a protective vaccine against human immunodeficiency virus type 1; there has been little success. However, the identification of broadly neutralizing antibodies against epitopes on the highly conserved membrane-proximal external region (MPER) of the gp41 envelope protein has delineated this region as an attractive vaccine target. Furthermore, emerging structural information on the MPER has provided vaccine designers with new insights for building relevant immunogens. This review describes the current state of the field regarding (i) the structure and function of the gp41 MPER; (ii) the structure and binding mechanisms of the broadly neutralizing antibodies 2F5, 4E10, and Z13; and (iii) the development of an MPER-targeting vaccine. In addition, emerging approaches to vaccine design are presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunobiology: the immune system in health and disease
(1995) · Choice Reviews Online · doi:10.5860/choice.32-3876 · Cited by 4,110
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
Dalgleish, A. G., Beverley, P. C. L., Clapham, P. R., Crawford, D. H., Greaves, M. F., & Weiss, R. A. (1984) · Nature · doi:10.1038/312763a0 · Cited by 3,533
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease
Berger, E. A., Murphy, P. M., & Farber, J. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.657 · Cited by 2,180
Predominant Autoantibody Production by Early Human B Cell Precursors
Wardemann, H., Yurasov, S., Schaefer, A., Young, J. W., Meffre, E., & Nussenzweig, M. C. (2003) · Science · doi:10.1126/science.1086907 · Cited by 2,083
Core Structure of gp41 from the HIV Envelope Glycoprotein
Chan, D. C., Fass, D., Berger, J. M., & Kim, P. S. (1997) · Cell · doi:10.1016/s0092-8674(00)80205-6 · Cited by 1,959
Atomic structure of the ectodomain from HIV-1 gp41
Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J., & Wiley, D. C. (1997) · Nature · doi:10.1038/387426a0 · Cited by 1,622
The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens
Wyatt, R., & Sodroski, J. (1998) · Science · doi:10.1126/science.280.5371.1884 · Cited by 1,598
Mascola, J. R., Stiegler, G., VanCott, T. C., Katinger, H., Carpenter, C. B., Hanson, C. E., Beary, H., Hayes, D., Frankel, S. S., Birx, D. L., et al. (2000) · Nature Medicine · doi:10.1038/72318 · Cited by 1,250
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
Richman, D. D., Wrin, T., Little, S. J., & Petropoulos, C. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630530100 · Cited by 1,200
Trkola, A., Purtscher, M., Muster, T., Ballaun, C., Buchacher, A., Sullivan, N., Srinivasan, K., Sodroski, J., Moore, J. P., & Katinger, H. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.1100-1108.1996 · Cited by 1,114
Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody
Burton, D. R., Pyati, J., Koduri, R., Sharp, S. J., Thornton, G. B., Parren, P. W. H. I., Sawyer, L. S. W., Hendry, R. M., Dunlop, N., Nara, P. L., et al. (1994) · Science · doi:10.1126/science.7973652 · Cited by 1,100
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
Muster, T., Steindl, F., Purtscher, M., Trkola, A., Klima, A., Himmler, G., Rüker, F., & Katinger, H. (1993) · Journal of Virology · doi:10.1128/jvi.67.11.6642-6647.1993 · Cited by 1,004
Kilby, J. M., Hopkins, S., Venetta, T. M., DiMassimo, B., Cloud, G. A., Lee, J. Y., Alldredge, L., Hunter, E., Lambert, D., Bolognesi, D., et al. (1998) · Nature Medicine · doi:10.1038/3293 · Cited by 987
Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design
Saphire, E. O., Parren, P. W. H. I., Pantophlet, R., Zwick, M. B., Morris, G. M., Rudd, P. M., Dwek, R. A., Stanfield, R. L., Burton, D. R., & Wilson, I. A. (2001) · Science · doi:10.1126/science.1061692 · Cited by 942
Wild, C. T., Shugars, D. C., Greenwell, T. K., McDanal, C. B., & Matthews, T. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9770 · Cited by 931
The Preference of Tryptophan for Membrane Interfaces
Yau, W.-M., Wimley, W. C., Gawrisch, K., & White, S. H. (1998) · Biochemistry · doi:10.1021/bi980809c · Cited by 926
Fc receptor but not complement binding is important in antibody protection against HIV
Hessell, A. J., Hangartner, L., Hunter, M., Havenith, C. E. G., Beurskens, F. J., Bakker, J. M., Lanigan, C. M. S., Landucci, G., Forthal, D. N., Parren, P. W. H. I., et al. (2007) · Nature · doi:10.1038/nature06106 · Cited by 901
Zwick, M. B., Labrijn, A. F., Wang, M., Spenlehauer, C., Saphire, E. O., Binley, J. M., Moore, J. P., Stiegler, G., Katinger, H., Burton, D. R., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10892-10905.2001 · Cited by 797
Mascola, J. R., Lewis, M. G., Stiegler, G., Harris, D., VanCott, T. C., Hayes, D., Louder, M. K., Brown, C. R., Sapan, C. V., Frankel, S. S., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4009-4018.1999 · Cited by 783
Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition
Calarese, D. A., Scanlan, C. N., Zwick, M. B., Deechongkit, S., Mimura, Y., Kunert, R., Zhu, P., Wormald, M. R., Stanfield, R. L., Roux, K. H., et al. (2003) · Science · doi:10.1126/science.1083182 · Cited by 781
Distribution and three-dimensional structure of AIDS virus envelope spikes
Zhu, P., Liu, J., Bess, J., Chertova, E., Lifson, J. D., Grisé, H., Ofek, G. A., Taylor, K. A., & Roux, K. H. (2006) · Nature · doi:10.1038/nature04817 · Cited by 780
Diversity in the CDR3 Region of VH Is Sufficient for Most Antibody Specificities
Xu, J. L., & Davis, M. M. (2000) · Immunity · doi:10.1016/s1074-7613(00)00006-6 · Cited by 779 · cited 1×
“The CDR-H3 region of an Ab is normally crucial to its interaction with antigen (253); thus, it is reasonable to assume that if the H3 region is not engaged in interactions with the peptide epitopes, it may contact some other component(s) of the viral surface.”
BackgroundStructural definition of a conserved neutralization epitope on HIV-1 gp120
Zhou, T., Xu, L., Dey, B., Hessell, A. J., Van Ryk, D., Xiang, S.-H., Yang, X., Zhang, M.-Y., Zwick, M. B., Arthos, J., et al. (2007) · Nature · doi:10.1038/nature05580 · Cited by 770
Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies
Haynes, B. F., Fleming, J., St. Clair, E. W., Katinger, H., Stiegler, G., Kunert, R., Robinson, J., Scearce, R. M., Plonk, K., Staats, H. F., et al. (2005) · Science · doi:10.1126/science.1111781 · Cited by 744
Defective B cell tolerance checkpoints in systemic lupus erythematosus
Yurasov, S., Wardemann, H., Hammersen, J., Tsuiji, M., Meffre, E., Pascual, V., & Nussenzweig, M. C. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042251 · Cited by 717
Binley, J. M., Wrin, T., Korber, B., Zwick, M. B., Wang, M., Chappey, C., Stiegler, G., Kunert, R., Zolla-Pazner, S., Katinger, H., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.13232-13252.2004 · Cited by 705
A trimeric structural domain of the HIV-1 transmembrane glycoprotein
Lu, M., Blacklow, S. C., & Kim, P. S. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb1295-1075 · Cited by 701
Nested fullerene-like structures
Margulis, L., Salitra, G., Tenne, R., & Talianker, M. (1993) · Nature · doi:10.1038/365113b0 · Cited by 678
Antibodies, viruses and vaccines
Burton, D. R. (2002) · Nature Reviews Immunology · doi:10.1038/nri891 · Cited by 637
Thali, M., Moore, J. P., Furman, C., Charles, M., Ho, D. D., Robinson, J., & Sodroski, J. (1993) · Journal of Virology · doi:10.1128/jvi.67.7.3978-3988.1993 · Cited by 616
Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gpl60
Hallenberger, S., Bosch, V., Angliker, H., Shaw, E., Klenk, H.-D., & Garten, W. (1992) · Nature · doi:10.1038/360358a0 · Cited by 582
Melikyan, G. B., Markosyan, R. M., Hemmati, H., Delmedico, M. K., Lambert, D. M., & Cohen, F. S. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.2.413 · Cited by 576
Kuiken, C., Foley, B., Freed, E., Hahn, B., Marx, P., McCutchan, F., Mellors, J., Wolinsky, S., & Korber, B. (2002) · doi:10.2172/1184349 · Cited by 570
Atomic structure of a thermostable subdomain of HIV-1 gp41
Tan, K., Liu, J.-H., Wang, J.-H., Shen, S., & Lu, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12303 · Cited by 532
BUCHACHER, A., PREDL, R., STRUTZENBERGER, K., STEINFELLNER, W., TRKOLA, A., PURTSCHER, M., GRUBER, G., TAUER, C., STEINDL, F., JUNGBAUER, A., et al. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.359 · Cited by 529
Stiegler, G., Kunert, R., Purtscher, M., Wolbank, S., Voglauer, R., Steindl, F., & Katinger, H. (2001) · AIDS Research and Human Retroviruses · doi:10.1089/08892220152741450 · Cited by 517
Jiang, S., Lin, K., Strick, N., & Neurath, A. R. (1993) · Nature · doi:10.1038/365113a0 · Cited by 508
Trkola, A., Kuster, H., Rusert, P., Joos, B., Fischer, M., Leemann, C., Manrique, A., Huber, M., Rehr, M., Oxenius, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1244 · Cited by 502
Ofek, G., Tang, M., Sambor, A., Katinger, H., Mascola, J. R., Wyatt, R., & Kwong, P. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.19.10724-10737.2004 · Cited by 490
Capture of an early fusion-active conformation of HIV-1 gp41
Furuta, R. A., Wild, C. T., Weng, Y., & Weiss, C. D. (1998) · Nature Structural Biology · doi:10.1038/nsb0498-276 · Cited by 488
Cardoso, R. M. F., Zwick, M. B., Stanfield, R. L., Kunert, R., Binley, J. M., Katinger, H., Burton, D. R., & Wilson, I. A. (2005) · Immunity · doi:10.1016/j.immuni.2004.12.011 · Cited by 449
Aloia, R. C., Tian, H., & Jensen, F. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5181 · Cited by 440
Salzwedel, K., West, J. T., & Hunter, E. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.2469-2480.1999 · Cited by 422
Coiled Coils in Both Intracellular Vesicle and Viral Membrane Fusion
Skehel, J. J., & Wiley, D. C. (1998) · Cell · doi:10.1016/s0092-8674(00)81710-9 · Cited by 411
Lipids do influence protein function—the hydrophobic matching hypothesis revisited
Jensen, M. Ø., & Mouritsen, O. G. (2004) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2004.06.009 · Cited by 411
Three-dimensional solution structure of the 44kDa ectodomain of SIV gp41
Caffrey, M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4572 · Cited by 410
A General Model for the Transmembrane Proteins of HIV and Other Retroviruses
GALLAHER, W. R., BALL, J. M., GARRY, R. F., GRIFFIN, M. C., & MONTELARO, R. C. (1989) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1989.5.431 · Cited by 368
Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein.
Earl, P. L., Doms, R. W., & Moss, B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.2.648 · Cited by 359
A Broadly Neutralizing Human Monoclonal Antibody against gp41 of Human Immunodeficiency Virus Type 1
PURTSCHER, M., TRKOLA, A., GRUBER, G., BUCHACHER, A., PREDL, R., STEINDL, F., TAUER, C., BERGER, R., BARRETT, N., JUNGBAUER, A., et al. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.1651 · Cited by 347
Freed, E. O., & Martin, M. A. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.341-351.1996 · Cited by 335
Identifying epitopes of HIV-1 that induce protective antibodies
Zolla-Pazner, S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1307 · Cited by 326
Bomsel, M., Heyman, M., Hocini, H., Lagaye, S., Belec, L., Dupont, C., & Desgranges, C. (1998) · Immunity · doi:10.1016/s1074-7613(00)80610-x · Cited by 299
Neutralizing Antibody Responses in Acute Human Immunodeficiency Virus Type 1 Subtype C Infection
Gray, E. S., Moore, P. L., Choge, I. A., Decker, J. M., Bibollet-Ruche, F., Li, H., Leseka, N., Treurnicht, F., Mlisana, K., Shaw, G. M., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00239-07 · Cited by 299
Dorfman, T., Mammano, F., Haseltine, W. A., & Göttlinger, H. G. (1994) · Journal of Virology · doi:10.1128/jvi.68.3.1689-1696.1994 · Cited by 288 · cited 1×
“Other functions have been described for CT, including interaction with the viral matrix protein (48, 62, 72, 160, 260), targeting to vesicles (56, 129, 194), as well as interaction with other proteins (15, 102, 152, 171, 252).”
BackgroundMuster, T., Guinea, R., Trkola, A., Purtscher, M., Klima, A., Steindl, F., Palese, P., & Katinger, H. (1994) · Journal of Virology · doi:10.1128/jvi.68.6.4031-4034.1994 · Cited by 286
Freed, E. O., Delwart, E. L., Buchschacher, G. L., & Panganiban, A. T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.70 · Cited by 279
Zwick, M. B., Jensen, R., Church, S., Wang, M., Stiegler, G., Kunert, R., Katinger, H., & Burton, D. R. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1252-1261.2005 · Cited by 278
Alam, S. M., McAdams, M., Boren, D., Rak, M., Scearce, R. M., Gao, F., Camacho, Z. T., Gewirth, D., Kelsoe, G., Chen, P., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4424 · Cited by 260
Identification of the Fusion Peptide of Primate Immunodeficiency Viruses
Bosch, M. L., Earl, P. L., Fargnoli, K., Picciafuoco, S., Giombini, F., Wong-Staal, F., & Franchini, G. (1989) · Science · doi:10.1126/science.2541505 · Cited by 250
GP120: Biologic Aspects of Structural Features
Poignard, P., Saphire, E. O., Parren, P. W., & Burton, D. R. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.253 · Cited by 249
The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity.
Parren, P. W. H. I., Moore, J. P., Burton, D. R., & Sattentau, Q. J. (1999) · PubMed · Cited by 248
Pantophlet, R., Saphire, E. O., Poignard, P., Parren, P. W. H. I., Wilson, I. A., & Burton, D. R. (2003) · Journal of Virology · doi:10.1128/jvi.77.1.642-658.2003 · Cited by 244
Gnann, J. W., Nelson, J. A., & Oldstone, M. B. (1987) · Journal of Virology · doi:10.1128/jvi.61.8.2639-2641.1987 · Cited by 242
Cryo-Electron Tomographic Structure of an Immunodeficiency Virus Envelope Complex In Situ
Zanetti, G., Briggs, J. A. G., Grünewald, K., Sattentau, Q. J., & Fuller, S. D. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020083 · Cited by 232
Muñoz-Barroso, I., Salzwedel, K., Hunter, E., & Blumenthal, R. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.6089-6092.1999 · Cited by 224
Wyma, D. J., Jiang, J., Shi, J., Zhou, J., Lineberger, J. E., Miller, M. D., & Aiken, C. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3429-3435.2004 · Cited by 223
Murakami, T., & Freed, E. O. (2000) · Journal of Virology · doi:10.1128/jvi.74.8.3548-3554.2000 · Cited by 213
Conley, A. J., Gorny, M. K., Kessler, J. A., Boots, L. J., Ossorio-Castro, M., Koenig, S., Lineberger, D. W., Emini, E. A., Williams, C., & Zolla-Pazner, S. (1994) · Journal of Virology · doi:10.1128/jvi.68.11.6994-7000.1994 · Cited by 211
Weissenhorn, W., Hinz, A., & Gaudin, Y. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.01.093 · Cited by 208
High resolution functional analysis of antibody-antigen interactions
Jin, L., Fendly, B. M., & Wells, J. A. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90636-x · Cited by 207
Lipid composition and fluidity of the human immunodeficiency virus.
Aloia, R. C., Jensen, F. C., Curtain, C. C., Mobley, P. W., & Gordon, L. M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.3.900 · Cited by 203
Alfsen, A., Iniguez, P., Bouguyon, E., & Bomsel, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.6257 · Cited by 197
Ohno, H., Aguilar, R. C., Fournier, M.-C., Hennecke, S., Cosson, P., & Bonifacino, J. S. (1997) · Virology · doi:10.1006/viro.1997.8839 · Cited by 195
Berlioz-Torrent, C., Shacklett, B. L., Erdtmann, L., Delamarre, L., Bouchaert, I., Sonigo, P., Dokhelar, M. C., & Benarous, R. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1350-1361.1999 · Cited by 195
Structural Rationale for the Broad Neutralization of HIV-1 by Human Monoclonal Antibody 447-52D
Stanfield, R. L., Gorny, M. K., Williams, C., Zolla-Pazner, S., & Wilson, I. A. (2004) · Structure · doi:10.1016/j.str.2004.01.003 · Cited by 194
Electron Tomography of the Contact between T Cells and SIV/HIV-1: Implications for Viral Entry
Sougrat, R., Bartesaghi, A., Lifson, J. D., Bennett, A. E., Bess, J. W., Zabransky, D. J., & Subramaniam, S. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030063 · Cited by 193
Dhillon, A. K., Donners, H., Pantophlet, R., Johnson, W. E., Decker, J. M., Shaw, G. M., Lee, F.-H., Richman, D. D., Doms, R. W., Vanham, G., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02749-06 · Cited by 192
Palmitoylation of the HIV-1 envelope glycoprotein is critical for viral infectivity
Rousso, I., Mixon, M. B., Chen, B. K., & Kim, P. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240459697 · Cited by 189
Lodge, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.4.695 · Cited by 186
Markosyan, R. M., Cohen, F. S., & Melikyan, G. B. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-09-0573 · Cited by 186
Nieva, J. L., Nir, S., Muga, A., Goni, F. M., & Wilschut, J. (1994) · Biochemistry · doi:10.1021/bi00177a009 · Cited by 184
Irving, M. B., Pan, O., & Scott, J. K. (2001) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00208-8 · Cited by 181
Self-citationSuárez, T., Gallaher, W. R., Agirre, A., et al. (2000) · Journal of Virology · doi:10.1128/jvi.74.17.8038-8047.2000 · Cited by 180
Gabuzda, D. H., Lever, A., Terwilliger, E., & Sodroski, J. (1992) · Journal of Virology · doi:10.1128/jvi.66.6.3306-3315.1992 · Cited by 176
A review of vaccine research and development: The human immunodeficiency virus (HIV)☆
GIRARD, M., OSMANOV, S., & KIENY, M. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.02.031 · Cited by 174
Edwards, T. G., Wyss, S., Reeves, J. D., Zolla-Pazner, S., Hoxie, J. A., Doms, R. W., & Baribaud, F. (2002) · Journal of Virology · doi:10.1128/jvi.76.6.2683-2691.2002 · Cited by 173
Stanfield, R. L., & Wilson, I. A. (1995) · Current Opinion in Structural Biology · doi:10.1016/0959-440x(95)80015-s · Cited by 173
Lodge, R., Göttlinger, H., Gabuzda, D., Cohen, É., & Lemay, G. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.4857-4861.1994 · Cited by 172
Nelson, J. D., Brunel, F. M., Jensen, R., Crooks, E. T., Cardoso, R. M. F., Wang, M., Hessell, A., Wilson, I. A., Binley, J. M., Dawson, P. E., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02588-06 · Cited by 172
Wyss, S., Berlioz‐Torrent, C., Boge, M., Blot, G., Höning, S., Bénarous, R., & Thali, M. (2001) · Journal of Virology · doi:10.1128/jvi.75.6.2982-2992.2001 · Cited by 169
Lawless, M. K., Barney, S., Guthrie, K. I., Bucy, T. B., Petteway, & Merutka, G. (1996) · Biochemistry · doi:10.1021/bi9606962 · Cited by 169
Schibli, D. J., Montelaro, R. C., & Vogel, H. J. (2001) · Biochemistry · doi:10.1021/bi010640u · Cited by 166
The Rational Design of an AIDS Vaccine
Douek, D. C., Kwong, P. D., & Nabel, G. J. (2006) · Cell · doi:10.1016/j.cell.2006.02.005 · Cited by 166
Gnann, J. W., Schwimmbeck, P. L., Nelson, J. A., Truax, A. B., & Oldstone, M. B. A. (1987) · Journal of Infectious Diseases · doi:10.1093/infdis/156.2.261 · Cited by 165
Antibody polyspecificity and neutralization of HIV-1: A hypothesis
Haynes, B. F., Moody, M. A., Verkoczy, L., Kelsoe, G., & Alam, S. M. (2006) · Human Antibodies · doi:10.3233/hab-2005-143-402 · Cited by 163
Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5
Purtscher, M., Trkola, A., Grassauer, A., Schulz, P. M., Klima, A., Döpper, S., Gruber, G., Buchacher, A., Muster, T., & Katinger, H. (1996) · AIDS · doi:10.1097/00002030-199606000-00003 · Cited by 162
Zwick, M. B., Wang, M., Poignard, P., Stiegler, G., Katinger, H., Burton, D. R., & Parren, P. W. H. I. (2001) · Journal of Virology · doi:10.1128/jvi.75.24.12198-12208.2001 · Cited by 160
Trkola, A., Ketas, T., KewalRamani, V. N., Endorf, F., Binley, J. M., Katinger, H., Robinson, J., Littman, D. R., & Moore, J. P. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.1876-1885.1998 · Cited by 160
Parker, C. E., Deterding, L. J., Hager-Braun, C., Binley, J. M., Schülke, N., Katinger, H., Moore, J. P., & Tomer, K. B. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10906-10911.2001 · Cited by 159
A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope
Miller, M. D., Geleziunas, R., Bianchi, E., Lennard, S., Hrin, R. C., Zhang, H., Lu, M., An, Z., Ingallinella, P., Finotto, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506927102 · Cited by 158
How Protein Transmembrane Segments Sense the Lipid Environment
Nyholm, T. K. M., Özdirekcan, S., & Killian, J. A. (2007) · Biochemistry · doi:10.1021/bi061941c · Cited by 156
A Study of the Membrane–Water Interface Region of Membrane Proteins
Granseth, E., von HEIJNE, G., & Elofsson, A. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.11.036 · Cited by 155
Meffre, E., Milili, M., Blanco-Betancourt, C., Antunes, H., Nussenzweig, M. C., & Schiff, C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13051 · Cited by 152
Pereira, F. B., Goñi, F. M., Muga, A., & Nieva, J. L. (1997) · Biophysical Journal · doi:10.1016/s0006-3495(97)78228-6 · Cited by 146
Yu, X., Yuan, X., McLane, M. F., Lee, T. H., & Essex, M. (1993) · Journal of Virology · doi:10.1128/jvi.67.1.213-221.1993 · Cited by 141
Brunel, F. M., Zwick, M. B., Cardoso, R. M. F., Nelson, J. D., Wilson, I. A., Burton, D. R., & Dawson, P. E. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.1680-1687.2006 · Cited by 137
Barbato, G., Bianchi, E., Ingallinella, P., Hurni, W. H., Miller, M. D., Ciliberto, G., Cortese, R., Bazzo, R., Shiver, J. W., & Pessi, A. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00611-9 · Cited by 136
Cardoso, R. M. F., Brunel, F. M., Ferguson, S., Zwick, M. B., Burton, D. R., Dawson, P. E., & Wilson, I. A. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.10.088 · Cited by 132
Alfsen, A., & Bomsel, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200554200 · Cited by 128
Zwick, M. B., Komori, H. K., Stanfield, R. L., Church, S., Wang, M., Parren, P. W. H. I., Kunert, R., Katinger, H. W. D., Wilson, I. A., & Burton, D. R. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.3155-3161.2004 · Cited by 124
Coëffier, E., Clément, J.-M., Cussac, V., et al. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00267-x · Cited by 123
Golding, H., Zaitseva, M. B., de Rosny, E., King, L. R., Manischewitz, J. F., Sidorov, I. A., Górny, M. K., Zolla‐Pazner, S., Dimitrov, D. S., & Weiss, C. D. (2002) · Journal of Virology · doi:10.1128/jvi.76.13.6780-6790.2002 · Cited by 122
Robinson, W. E., Kawamura, T., Górny, M. K., Lake, D. F., Xu, J. Y., Matsumoto, Y., Sugano, T., Masuho, Y., Mitchell, W. M., & Hersh, E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.8.3185 · Cited by 122
AIDS virus envelope spike structure
Roux, K. H., & Taylor, K. A. (2007) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2007.03.008 · Cited by 121
Alam, S. M., Scearce, R. M., Parks, R., Plonk, K., Plonk, S. G., Sutherland, L. L., Górny, M. K., Zolla‐Pazner, S., Vanleeuwen, S., Moody, M. A., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00927-07 · Cited by 120
Chernomordik, L., Chanturiya, A., Suss-Toby, E., Nora, E., & Zimmerberg, J. J. (1994) · Journal of Virology · doi:10.1128/jvi.68.11.7115-7123.1994 · Cited by 115
Deschambeault, J., Lalonde, J.-P., Cervantes-Acosta, G., Lodge, R., Cohen, É. A., & Lemay, G. (1999) · Journal of Virology · doi:10.1128/jvi.73.6.5010-5017.1999 · Cited by 111
A Structural Correlation Between Lentivirus Transmembrane Proteins and Natural Cytolytic Peptides
Miller, M. A., Garry, R. F., Jaynes, J. M., & Montelaro, R. C. (1991) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1991.7.511 · Cited by 109
Weiss, C. D., & White, J. M. (1993) · Journal of Virology · doi:10.1128/jvi.67.12.7060-7066.1993 · Cited by 108
In Vivo and In Vitro Escape from Neutralizing Antibodies 2G12, 2F5, and 4E10
Manrique, A., Rusert, P., Joos, B., Fischer, M., Kuster, H., Leemann, C., Niederöst, B., Weber, R. K., Stiegler, G. M., Katinger, H. W. D., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00598-07 · Cited by 108
Orientation and structure of the NH2-terminal HIV-1 gp41 peptide in fused and aggregated liposomes
Martin, I., Defrise-Quertain, F., Decroly, É., Vandenbranden, M., Brasseur, R., & Ruysschaert, J. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90389-h · Cited by 108
Srinivas, S., Srinivas, R. V., Anantharamaiah, G. M., Segrest, J. P., & Compans, R. W. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50546-4 · Cited by 105
Srinivas, S., Srinivas, R. V., Anantharamaiah, G. M., Compans, R. W., & Segrest, J. P. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41610-9 · Cited by 104
Wild, C. T., Greenwell, T., Shugars, D. C., Rimsky, L. T., & Matthews, T. J. (1995) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1995.11.323 · Cited by 104
Li, Y., & Tamm, L. K. (2007) · Biophysical Journal · doi:10.1529/biophysj.106.102335 · Cited by 103
McGaughey, G. B., Citron, M. P., Danzeisen, R. C., Freidinger, R. M., Garsky, V. M., Hurni, W. M., Joyce, J. G., Liang, X., Miller, M. D., Shiver, J. W., et al. (2003) · Biochemistry · doi:10.1021/bi026952u · Cited by 103
Suárez, T., Nir, S., Goñi, F. M., Sáez‐Cirión, A., & Nieva, J. L. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01785-3 · Cited by 94
Stoichiometry of Antibody Neutralization of Human Immunodeficiency Virus Type 1
Yang, X., Kurteva, S., Lee, S., & Sodroski, J. (2005) · Journal of Virology · doi:10.1128/jvi.79.6.3500-3508.2005 · Cited by 93
Solid-Phase Proteoliposomes Containing Human Immunodeficiency Virus Envelope Glycoproteins
Grundner, C., Mirzabekov, T. A., Sodroski, J., & Wyatt, R. T. (2002) · Journal of Virology · doi:10.1128/jvi.76.7.3511-3521.2002 · Cited by 92
Are fusion peptides a good model to study viral cell fusion?
Nieva, J. L., & Agirre, A. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(03)00168-8 · Cited by 91
Raulin, J. (2002) · Progress in Lipid Research · doi:10.1016/s0163-7827(01)00019-4 · Cited by 91
de Rosny, E., Vassell, R. A., Jiang, S., Kunert, R., & Weiss, C. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.5.2627-2631.2004 · Cited by 91
Law, M., Cardoso, R. M. F., Wilson, I. A., & Burton, D. R. (2007) · Journal of Virology · doi:10.1128/jvi.02536-06 · Cited by 88
HIV-1 gp41: mediator of fusion and target for inhibition.
Weiss, C. D. (2003) · PubMed · Cited by 86
A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs
Matoba, N., Magérus, A., Geyer, B. C., Zhang, Y., Muralidharan, M., Alfsen, A., Arntzen, C. J., Bomsel, M., & Mor, T. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405297101 · Cited by 86
Guo, Y., Chen, C., Zheng, Y., Zhang, J., Tao, X., Liu, S., Zheng, D., & Liu, Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503621200 · Cited by 85
Bellamy-McIntyre, A. K., Lay, C.-S., Bär, S., Maerz, A. L., Talbo, G. H., Drummer, H. E., & Poumbourios, P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703485200 · Cited by 85
Liang, X., Munshi, S., Shendure, J., Mark, G., Davies, M. E., Freed, D. C., Montefiori, D. C., & Shiver, J. W. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00125-5 · Cited by 84
Dimitrov, A. S., Jacobs, A., Finnegan, C. M., Stiegler, G. M., Katinger, H. W. D., & Blumenthal, R. (2007) · Biochemistry · doi:10.1021/bi062245f · Cited by 84
Gray, E. S., Meyers, T., Gray, G., Montefiori, D. C., & Morris, L. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030255 · Cited by 82
Schaal, H., Klein, M., Gehrmann, P., Adams, O., & Scheid, A. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3308-3314.1995 · Cited by 77
Miyauchi, K., Komano, J. A., Yokomaku, Y., Sugiura, W., Yamamoto, N., & Matsuda, Z. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.4720-4729.2005 · Cited by 74
Structural basis of peptide–carbohydrate mimicry in an antibody-combining site
Vyas, N. K., Vyas, M. N., Chervenak, M. C., Bundle, D. R., Pinto, B. M., & Quiocho, F. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2431286100 · Cited by 73
Salzwedel, K., Johnston, P. B., Roberts, S. J., Dubay, J. W., & Hunter, E. (1993) · Journal of Virology · doi:10.1128/jvi.67.9.5279-5288.1993 · Cited by 72
Grothaus, M. C., Srivastava, N., Smithson, S. L., Kieber‐Emmons, T., Williams, D. B., Carlone, G. M., & Westerink, M. A. J. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00390-4 · Cited by 72
Piller, S. C., Dubay, J. W., Derdeyn, C. A., & Hunter, E. (2000) · Journal of Virology · doi:10.1128/jvi.74.24.11717-11723.2000 · Cited by 72
Kliger, Y., & Shai, Y. (1997) · Biochemistry · doi:10.1021/bi962935r · Cited by 69
Devito, C., Zuber, B., Schröder, U., Benthin, R., Okuda, K., Broliden, K., Wahrén, B., & Hinkula, J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.7078 · Cited by 67
Saphire, E. O., Montero, M., Menéndez, A., van Houten, N. E., Irving, M. B., Pantophlet, R. A., Zwick, M. B., Parren, P. W. H. I., Burton, D. R., Scott, J. K., et al. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.01.060 · Cited by 66
Self-citationBeenhouwer, D. O., May, R. J., Valadon, P., & Scharff, M. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.12.6992 · Cited by 66
Dimitrov, A. S., Louis, J. M., Bewley, C. A., Clore, G. M., & Blumenthal, R. (2005) · Biochemistry · doi:10.1021/bi051092d · Cited by 64
Hovanessian, A. G., Briand, J., Said, E. A., Svab, J., Ferris, S., Dali, H., Muller, S., Des̀granges, C., & Krust, B. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.015 · Cited by 64
Joos, B., Trkola, A., Kuster, H., Aceto, L., Fischer, M., Stiegler, G. M., Armbruster, C., Vcelar, B. A., Katinger, H. W. D., & Günthard, H. F. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1773-1779.2006 · Cited by 64
Brown, B. K., Karasavvas, N., Beck, Z., Matyas, G. R., Birx, D. L., Polonis, V. R., & Alving, C. R. (2006) · Journal of Virology · doi:10.1128/jvi.02011-06 · Cited by 63
Preparation and Characterization of Human HIV Type 1 Neutralizing Reference Sera
Vujcic, L. K., & Quinnan, G. V. (1995) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1995.11.783 · Cited by 62
Zhang, H., Huang, Y., Fayad, R., Spear, G. T., & Qiao, L. (2004) · Journal of Virology · doi:10.1128/jvi.78.15.8342-8348.2004 · Cited by 58
Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure
Poumbourios, P., Ahmar, W., McPhee, D. A., & Kemp, B. E. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.1209-1218.1995 · Cited by 58
Crooks, E. T., Moore, P. L., Richman, D. D., Robinson, J. E., Crooks, J. A., Franti, M., Schülke, N., & Binley, J. Μ. (2006) · Human Antibodies · doi:10.3233/hab-2005-143-407 · Cited by 57
The Role of the Membrane-spanning Domain Sequence in Glycoprotein-mediated Membrane Fusion
Taylor, G. M., & Sanders, D. A. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.9.2803 · Cited by 56
Cleveland, S. M., McLain, L., Cheung, L., Jones, T. D., Hollier, M. J., & Dimmock, N. J. (2003) · Journal of General Virology · doi:10.1099/vir.0.18630-0 · Cited by 54
Zheng, Z., Yang, R., Bodner, M. L., & Weliky, D. P. (2006) · Biochemistry · doi:10.1021/bi0615902 · Cited by 51
Arroyo, J., Boceta, M., González, M. E., Michel, M., & Carrasco, L. (1995) · Journal of Virology · doi:10.1128/jvi.69.7.4095-4102.1995 · Cited by 50
Sánchez-Martínez, S., Lorizate, M., Katinger, H. W. D., Kunert, R., Basáñez, G., & Nieva, J. L. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.03.067 · Cited by 49
Matoba, N., Geyer, B. C., Kilbourne, J. A., Alfsen, A., Bomsel, M., & Mor, T. S. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.03.045 · Cited by 49
Korazim, O., Sackett, K., & Shai, Y. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.08.091 · Cited by 48
Zwick, M. B., Saphire, E. O., & Burton, D. R. (2004) · Nature Medicine · doi:10.1038/nm0204-133 · Cited by 45
Trimeric Membrane-anchored gp41 Inhibits HIV Membrane Fusion
Lenz, O., Dittmar, M. T., Wagner, A., Ferko, B., Vorauer‐Uhl, K., Stiegler, G. M., & Weissenhorn, W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411088200 · Cited by 41
Pre‐transmembrane sequence of Ebola glycoprotein
Sáez‐Cirión, A., Gomara, M. J., Agirre, A., & Nieva, J. L. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03747-x · Cited by 41
Membrane-transferring Sequences of the HIV-1 Gp41 Ectodomain Assemble into an Immunogenic Complex
Lorizate, M., Gomara, M. J., de la Torre, B. G., Andreu, D., & Nieva, J. L. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.04.056 · Cited by 40
Anchoring mechanisms of membrane-associated M13 major coat protein
Stopar, D., Spruijt, R. B., & Hemminga, M. A. (2006) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2006.02.023 · Cited by 40
The HIV-Neutralizing Monoclonal Antibody 4E10 Recognizes N-Terminal Sequences on the Native Antigen
Hager‐Braun, C., Katinger, H. W. D., & Tomer, K. B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7471 · Cited by 36
Buratti, E., Cleveland, S. M., Baralle, F. E., McLain, L., Dimmock, N. J., & Tisminetzky, S. G. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-11-2709 · Cited by 35
Lin, X., Derdeyn, C. A., Blumenthal, R., West, J. T., & Hunter, E. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.7067-7077.2003 · Cited by 34
Moreno, M. R., Pascual, R., & Villalaı́n, J. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2003.12.003 · Cited by 32
Yang, R., Yang, J., & Weliky, D. P. (2003) · Biochemistry · doi:10.1021/bi027052g · Cited by 32
Martin, I., & Ruysschaert, J. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)00171-4 · Cited by 31
Immunogenicity of HIV Type 1 gp120 CD4 Binding Site Phage Mimotopes
Dorgham, K., Dogan, I., Bitton, N., Parizot, C., Cardona, V., Debré, P., Hartley, O., & Gorochov, G. (2005) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2005.21.82 · Cited by 30
Bu, Z., Ye, L., Vzorov, A., Taylor, D., Compans, R., & Yang, C.-L. (2004) · Virology · doi:10.1016/j.virol.2004.06.041 · Cited by 25
Poumbourios, P., McPhee, D. A., & Kemp, B. E. (1992) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1992.8.2055 · Cited by 25
Qiao, Z., Kim, M., Reinhold, B. B., Montefiori, D. C., Wang, J., & Reinherz, E. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414515200 · Cited by 25
Scheerlinck, J. Y., Deleys, R., Saman, E., Brys, L., Geldhof, A. B., & Baetselier, P. D. (1993) · Molecular Immunology · doi:10.1016/0161-5890(93)90144-z · Cited by 24
Yu, H., Alfsen, A., Tudor, D., & Bomsel, M. (2007) · Cell Calcium · doi:10.1016/j.ceca.2007.04.011 · Cited by 24
The SIV Surface Spike Imaged by Electron Tomography: One Leg or Three?
Subramaniam, S. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020091 · Cited by 24
Ni, J., Powell, R., Baskakov, I. V., DeVico, A. L., Lewis, G. K., & Wang, L. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.04.008 · Cited by 20
Liao, M., Lu, Y., Xiao, Y. Q., et al. (2000) · Peptides · doi:10.1016/s0196-9781(00)00179-0 · Cited by 18
Ou, W., Lü, N., Yu, S. S., & Silver, J. E. (2006) · Journal of Virology · doi:10.1128/jvi.80.5.2539-2547.2006 · Cited by 18
Effect of the conformation of a peptide from gp41 on binding and domain formation in model membranes
Koenig, B. W., Bergelson, L. D., Gawrisch, K., Ward, J., & Ferretti, J. A. (1995) · Molecular Membrane Biology · doi:10.3109/09687689509038499 · Cited by 17
Welman, M., Lemay, G., & Cohen, É. A. (2006) · Virus Research · doi:10.1016/j.virusres.2006.10.009 · Cited by 17
Dimmock, N. J. (2005) · Reviews in Medical Virology · doi:10.1002/rmv.476 · Cited by 14
Ya-bin, Guo, Caifeng, Chen, Yong, Zheng, Jinchun, Zhang, C., Xiaohui, Tao, T., et al. (2006) · 中国生物学文摘 · Cited by 14
Veiga, A. S., & Castanho, M. A. R. B. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.02.002 · Cited by 12
Mohlbacher, M., Spruth, M., Siegel, F., Zangerle, R., & Dierich, M. P. (1999) · Immunobiology · doi:10.1016/s0171-2985(99)80078-3 · Cited by 10
Antigenic properties of a transport-competent influenza HA/HIV Env chimeric protein
鳥宮, 尚., Sun, Y., Lin, J., Bu, Z., Wu, Q., Jiang, S., Steinhauer, D. A., Compans, R. W., & Yang, C. (2006) · Virology · doi:10.1016/j.virol.2006.04.012 · Cited by 7
Cited by
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Walker, L. M., Phogat, S. K., Chan-Hui, P.-Y., Wagner, D., Phung, P., Goss, J. L., Wrin, T., Simek, M. D., Fling, S., Mitcham, J. L., et al. (2009) · Science · doi:10.1126/science.1178746 · Cited by 1,723
Tomaras, G. D., Yates, N. L., Liu, P., Qin, L., Fouda, G. G., Chavez, L. L., Decamp, A. C., Parks, R. J., Ashley, V. C., Lucas, J. T., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01708-08 · Cited by 631
Nanoparticulate STING agonists are potent lymph node–targeted vaccine adjuvants
Hanson, M. C., Crespo, M. P., Abraham, W., Moynihan, K. D., Szeto, G. L., Chen, S. H., Melo, M. B., Mueller, S., & Irvine, D. J. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79915 · Cited by 381
Bomsel, M., Tudor, D., Drillet, A.-S., Alfsen, A., Ganor, Y., Roger, M.-G., Mouz, N., Amacker, M., Chalifour, A., Diomede, L., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.01.015 · Cited by 293
HIV-1 fusion inhibitors targeting the membrane-proximal external region of Env spikes
Xiao, T., Frey, G., Fu, Q., Lavine, C. L., Scott, D. A., Seaman, M. S., Chou, J. J., & Chen, B. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0496-y · Cited by 38
Metadata
- Authors
- Montero, M., van Houten, N. E., Wang, X., & Scott, J. K.
- Venue
- Microbiology and Molecular Biology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2008-03
- Volume
- 72
- Issue
- 1
- Pages
- 54-84
- ISSN
- 1092-2172 (ISSN-L)
- 1098-5557
- OpenAlex
- W2127072493
- Cited by
- 253
- References
- 193
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.